- Home
- TOL vs TEM Comparison
TOL vs TEM Comparison
Compare TOL & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOL
- TEM
- Stock Information
- Founded
- TOL 1967
- TEM 2015
- Country
- TOL United States
- TEM United States
- Employees
- TOL N/A
- TEM N/A
- Industry
- TOL Homebuilding
- TEM
- Sector
- TOL Consumer Discretionary
- TEM
- Exchange
- TOL Nasdaq
- TEM NYSE
- Market Cap
- TOL 11.9B
- TEM 11.2B
- IPO Year
- TOL N/A
- TEM 2024
- Fundamental
- Price
- TOL $121.98
- TEM $54.89
- Analyst Decision
- TOL Buy
- TEM Buy
- Analyst Count
- TOL 15
- TEM 12
- Target Price
- TOL $141.20
- TEM $65.09
- AVG Volume (30 Days)
- TOL 1.6M
- TEM 8.5M
- Earning Date
- TOL 08-19-2025
- TEM 08-08-2025
- Dividend Yield
- TOL 0.82%
- TEM N/A
- EPS Growth
- TOL N/A
- TEM N/A
- EPS
- TOL 13.50
- TEM N/A
- Revenue
- TOL $10,659,614,000.00
- TEM $803,315,000.00
- Revenue This Year
- TOL $1.23
- TEM $81.57
- Revenue Next Year
- TOL N/A
- TEM $24.86
- P/E Ratio
- TOL $9.03
- TEM N/A
- Revenue Growth
- TOL 1.59
- TEM 42.93
- 52 Week Low
- TOL $86.67
- TEM $31.36
- 52 Week High
- TOL $169.52
- TEM $91.45
- Technical
- Relative Strength Index (RSI)
- TOL 56.22
- TEM N/A
- Support Level
- TOL $117.50
- TEM N/A
- Resistance Level
- TOL $124.39
- TEM N/A
- Average True Range (ATR)
- TOL 3.61
- TEM 0.00
- MACD
- TOL -0.47
- TEM 0.00
- Stochastic Oscillator
- TOL 54.44
- TEM 0.00
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US. It has its headquarters in Horsham, Pennsylvania.
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.